B
Berrak Ç. Yeğen
Researcher at Marmara University
Publications - 253
Citations - 7365
Berrak Ç. Yeğen is an academic researcher from Marmara University. The author has contributed to research in topics: Malondialdehyde & Myeloperoxidase. The author has an hindex of 45, co-authored 233 publications receiving 6723 citations. Previous affiliations of Berrak Ç. Yeğen include Istanbul Technical University.
Papers
More filters
Journal ArticleDOI
Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms
Neşe I˙meryüz,Berrak Ç. Yeğen,Ayhan Bozkurt,Tamer Coskun,Maria L. Villanueva-Peñacarrillo,N.B. Ulusoy +5 more
TL;DR: In gastric fistula rats, vagal afferent denervation and peripheral administration of the GLP-1 receptor antagonist exendin enhanced emptying of a glucose meal, whereas intracerebroventricularExendin was ineffective, and the notion that GLP1 receptors participate in the central and peripheral regulation of gastric function is supported.
Journal ArticleDOI
Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats.
TL;DR: The present study suggests that melatonin may be of therapeutic benefit when used with MTX and elucidates the role of free radicals in MTX‐induced toxicity and the protection by melatonin.
Journal ArticleDOI
β-glucan ameliorates methotrexate-induced oxidative organ injury via its antioxidant and immunomodulatory effects
TL;DR: The findings of the present study suggest that beta-glucan, through its antioxidant and immunoregulatory effects, may be of therapeutic value in alleviating the leukocyte apoptosis, oxidative tissue injury and thereby the intestinal and hepatorenal side effects of methotrexate treatment.
Journal ArticleDOI
Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death.
Mustafa Çetiner,Göksel Şener,A. Özer Şehirli,Emel Eksioglu-Demiralp,Feriha Ercan,Serap Sirvanci,Nursal Gedik,Sertac Akpulat,Tulay Tecimer,Berrak Ç. Yeğen +9 more
TL;DR: It appears that taurine protects against methotrexate-induced oxidant organ injury and inhibits leukocyte apoptosis and may be of therapeutic potential in alleviating the systemic side effects of chemotherapeutics.
Journal ArticleDOI
Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage.
Elif Tatlıdede,Özer Şehirli,Ayliz Velioğlu-Öğünç,Şule Çetinel,Berrak Ç. Yeğen,Aysen Yarat,Selami Süleymanoğlu,Göksel Şener +7 more
TL;DR: RVT markedly ameliorated the severity of cardiac dysfunction, while all oxidant responses were prevented, implicating that RVT may be of therapeutic use in preventing oxidative stress due to DOX toxicity.